FI940697A - Condensed 5-membered heterocycles, process for their preparation and these compounds containing drug - Google Patents

Condensed 5-membered heterocycles, process for their preparation and these compounds containing drug Download PDF

Info

Publication number
FI940697A
FI940697A FI940697A FI940697A FI940697A FI 940697 A FI940697 A FI 940697A FI 940697 A FI940697 A FI 940697A FI 940697 A FI940697 A FI 940697A FI 940697 A FI940697 A FI 940697A
Authority
FI
Finland
Prior art keywords
condensed
preparation
compounds containing
containing drug
membered heterocycles
Prior art date
Application number
FI940697A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940697A0 (en
Inventor
Volkhard Austel
Helmut Pieper
Frank Himmelsbach
Guenter Linz
Thomas Mueller
Johannes Weisenberger
Brian Guth
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI940697A0 publication Critical patent/FI940697A0/en
Publication of FI940697A publication Critical patent/FI940697A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
FI940697A 1993-02-16 1994-02-15 Condensed 5-membered heterocycles, process for their preparation and these compounds containing drug FI940697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4304650A DE4304650A1 (en) 1993-02-16 1993-02-16 Condensed 5-membered heterocycles, processes for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
FI940697A0 FI940697A0 (en) 1994-02-15
FI940697A true FI940697A (en) 1994-08-17

Family

ID=6480585

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940697A FI940697A (en) 1993-02-16 1994-02-15 Condensed 5-membered heterocycles, process for their preparation and these compounds containing drug

Country Status (10)

Country Link
EP (1) EP0611660A3 (en)
JP (1) JPH072839A (en)
AU (1) AU5513094A (en)
CA (1) CA2115737A1 (en)
DE (1) DE4304650A1 (en)
FI (1) FI940697A (en)
IL (1) IL108648A0 (en)
NO (1) NO940524D0 (en)
NZ (1) NZ250879A (en)
ZA (1) ZA941021B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751647B1 (en) * 1996-07-25 1998-09-11 Synthelabo BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS
PL340412A1 (en) 1997-10-20 2001-01-29 Hoffmann La Roche Bicyclic kinase inhibitors
EP1379520B2 (en) 2001-02-23 2014-04-09 Merck Sharp & Dohme Corp. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
YU37904A (en) 2001-11-09 2006-08-17 Boehringer Ingelheim Pharmaceuticals Inc. Benzimidazoles useful as protein kinase inhibitors
AU2003257094A1 (en) 2002-08-08 2004-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
PT1988397E (en) 2002-12-19 2011-12-02 Scripps Research Inst Compositions and uses for stabilising transthyretin and inhibiting transthyretin misfolding
EP1479676A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Benzimidazole-derivatives as factor xa inhibitors
US7741341B2 (en) 2003-05-19 2010-06-22 Sanofi-Aventis Deutschland Gmbh Benzimidazole-derivatives as factor Xa inhibitors
CA2534649A1 (en) 2003-08-01 2005-02-10 Genelabs Technologies, Inc. Bicyclic imidazol derivatives against flaviviridae
WO2005113523A1 (en) 2004-05-20 2005-12-01 Foldrx Pharmaceuticals, Inc. 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
WO2009086077A2 (en) * 2007-12-21 2009-07-09 Endacea, Inc. A1 adenosine receptor antagonists
JP5869677B2 (en) 2011-09-16 2016-02-24 ファイザー・インク Solid form of transthyretin dissociation inhibitor
WO2014125084A1 (en) 2013-02-14 2014-08-21 Technische Universität München Hydroxyindalpine derivatives and their medical use
US9186361B2 (en) 2013-03-15 2015-11-17 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
JP6360149B2 (en) 2013-03-15 2018-07-18 ハイドラ バイオサイエンシズ インコーポレイテッドHydra Biosciences,Inc. Substituted xanthines and methods of use
US9233961B2 (en) 2013-03-15 2016-01-12 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US9296754B2 (en) 2013-03-15 2016-03-29 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
SG11201604618TA (en) 2013-12-19 2016-07-28 Novartis Ag [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis
US10112901B2 (en) 2014-07-03 2018-10-30 Shanghai Institute Of Pharmaceutical Industry Method for preparing dabigatran etexilate intermediate, and intermediate compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208367B (en) 1987-07-09 1991-07-03 Alcatel Business Systems Franking machine
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
DE4129603A1 (en) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS
DE4214245A1 (en) * 1992-04-30 1993-11-04 Thomae Gmbh Dr K Labelled fibrinogen receptor antagonists
DE59303178D1 (en) * 1992-04-28 1996-08-14 Thomae Gmbh Dr K Tritiated fibrinogen receptor antagonists, their use and methods for their preparation

Also Published As

Publication number Publication date
NO940524D0 (en) 1994-02-15
EP0611660A3 (en) 1994-09-14
DE4304650A1 (en) 1994-08-18
CA2115737A1 (en) 1994-08-17
ZA941021B (en) 1995-08-15
EP0611660A2 (en) 1994-08-24
FI940697A0 (en) 1994-02-15
JPH072839A (en) 1995-01-06
IL108648A0 (en) 1994-05-30
NO940524L (en) 1994-08-17
NZ250879A (en) 1995-09-26
AU5513094A (en) 1994-08-18

Similar Documents

Publication Publication Date Title
FI940378A (en) 5-membered heterocycles, process for their preparation and drugs containing these compounds
FI940697A (en) Condensed 5-membered heterocycles, process for their preparation and these compounds containing drug
EP0525629A3 (en) 5-membered heterocycles, process for their preparation and medicaments containing them
ZA926700B (en) Condensed 5-membered heterocyclic compounds processes for preparing them and pharmaceutical preparations containing these compounds
DE69005858T3 (en) Heterocyclic compounds.
DE69018647T2 (en) DRUG.
NO933248D0 (en) Cyclic urea derivatives, drugs containing these compounds, and processes for their preparation
FI973518A0 (en) Pharmaceutical composition for piperidinoalkanol compounds
FI20000084A (en) Process for preparing an antifungal pharmaceutical composition
FI943579A (en) Benzo-condensed heterocyclic compounds with 5-membered ring, process for their preparation, their use as drugs, their use as diagnostics and drugs containing said compounds
NO944700D0 (en) New Thienothiazine Derivatives, Process for their Preparation and Pharmaceutical Preparations Containing the Compounds
FI972646A0 (en) Piperazine derivatives, these compounds containing drugs, their use and process for their preparation
DE69133088T2 (en) PHARMACEUTICAL EFFECTIVE BENZOCHINAZOLINE COMPOUNDS
ZA965712B (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
DK0562583T3 (en) Novel alkylenediamonium diclavulanate derivatives, process for their preparation and use thereof
FI935654A (en) Condensed heterocyclic compounds, their preparation and use
DK114189D0 (en) BENZOCYCLOHEPTENDER DERIVATIVES, AND MEDICINAL PRODUCTS CONTAINING SUCH COMPOUNDS
EP0572308A3 (en) Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
NO913162D0 (en) PHARMACEUTICAL PREPARATION FOR TONSILLITE TREATMENT.
DK532189A (en) ROLLER, DELIVERY CONTAINER
KR950703559A (en) Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same
AU7750691A (en) Disposable container for single dosage applications
FI892288A (en) PHARMACEUTICAL REQUIREMENTS FOR TRAMMERS.
FI934317A0 (en) PHARMACEUTICAL SAMMANSAETTNINGAR, VILKA INNEHAOLLER EJ-JONISKA YTAKTIVA AEMNEN
ATE123280T1 (en) HETEROCYCLIC COMPOUNDS.

Legal Events

Date Code Title Description
FD Application lapsed